Portfolio company
A3P Biomedical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
A3P Biomedical provides the Stockholm3 blood test for early prostate cancer screening to healthcare providers and laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aqtual
This company develops blood-based tests to predict therapy response and monitor chronic diseases like rheumatoid arthritis and cancer for healthcare providers.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Cleveland Diagnostics
This company develops blood-based protein biomarker tests for early cancer detection to help clinicians and laboratories identify high-risk patients and reduce unnecessary biopsies.
Promental Health
Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.
Aescolab
Aescolab provides AI-driven blood biomarker analysis and personalised lifestyle reports for individuals and corporate employees to improve health and reduce workplace sick days.
Aerion Bioscience
This company develops a blood test using a six-protein panel and algorithm to detect lung cancer in high-risk individuals.
Epigenomics
This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.
Blue Earth
This company develops molecular imaging agents and radiopharmaceutical therapies for healthcare professionals to diagnose and treat patients with prostate cancer.
